Pathways’ Picks July 12: Medicare Mélange and More from FDA, Europe, and China

article image

In this week’s roundup: Industry presses against New Tech Add-on Payment process updates, watching for physician and outpatient proposals, carotid stenting coverage expansion, and more Medicare news. Also: FDA removes paclitaxel warning; Europe designates a new notified body; China issues AI guidance; and additional updates from China, the US, EU, and Australia.

Next Picks

What we’re watching for:

MDMA to meet on NTAP. The Medical Device Manufacturers Association will meet with Biden administration officials next week to try to head off proposed changes by CMS to the New Technology Add-on Payment (NTAP) application process. Companies say the planned updates would unnecessarily restrict access to the bonus payment program for a significant number of devices. For more details, see “Device Firms Oppose CMS Plans to Curb New Tech Pay Applications.”


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: